Mylan's story in Turkey began with a liaison office in 2007, when MEDA Pharmaceutical transitioned from distributors to its own licensed brands.
This story continued rapidly when Mylan, one of the world's leading specific and generic pharmaceutical companies, selling in 165 countries and regions, joined forces by purchasing MEDA worldwide in 2016.
Mylan Turkey has been operating in Turkey for ten years to provide the best treatment for patients and healthcare professionals with original products and is one of the 50 largest pharmaceutical companies. Mylan Turkey currently has a specific product portfolio, mainly in the fields of Pain, Inflammation, Allergy and Dermatology.
